Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · IEX Real-Time Price · USD
27.04
0.00 (0.00%)
Jul 22, 2024, 10:28 AM EDT - Market open
Tarsus Pharmaceuticals Employees
Tarsus Pharmaceuticals had 244 employees as of December 31, 2023. The number of employees increased by 157 or 180.46% compared to the previous year.
Employees
244
Change (1Y)
157
Growth (1Y)
180.46%
Revenue / Employee
$174,430
Profits / Employee
-$607,398
Market Cap
1.02B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 244 | 157 | 180.46% |
| Dec 31, 2022 | 87 | 41 | 89.13% |
| Dec 31, 2021 | 46 | 26 | 130.00% |
| Dec 31, 2020 | 20 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| OPKO Health | 3,930 |
| Avanos Medical | 3,771 |
| Calliditas Therapeutics AB (publ) | 217 |
| Tango Therapeutics | 140 |
| Cullinan Oncology | 85 |
| Pharvaris | 82 |
| Pulse Biosciences | 56 |
| Tyra Biosciences | 49 |
TARS News
- 7 weeks ago - Tarsus to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Tarsus to Participate in Fireside Chat at the 2024 Bank of America Healthcare Conference - GlobeNewsWire
- 2 months ago - Tarsus Reports First Quarter 2024 Financial Results and Recent Business Achievements - GlobeNewsWire
- 2 months ago - Tarsus to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024 - GlobeNewsWire
- 3 months ago - Tarsus Strengthens Financial Position and Refinances Existing Debt with $200 Million Non-dilutive Financing Commitment from Pharmakon - GlobeNewsWire
- 4 months ago - Tarsus to Participate at Upcoming Investor Conferences - GlobeNewsWire
- 4 months ago - Tarsus Introduces “Mite Party” Campaign for XDEMVY® (lotilaner ophthalmic solution) 0.25% to Educate Consumers about Demodex Blepharitis - GlobeNewsWire
- 5 months ago - Tarsus Announces Pricing of $100.0 Million Public Offering - GlobeNewsWire